Denmark has significantly lowered its economic growth projection for 2025, revising it to 1.4% from the earlier forecast of 3%, according to government documents reviewed by Bloomberg News. The downward adjustment reflects deteriorating conditions tied to Novo Nordisk A/S, the country’s pharmaceutical leader, whose performance is closely linked to national economic health. External pressures, including increased tariffs in the United States and a less favorable global outlook for the pharmaceutical sector, have contributed to the decision. These factors have prompted Danish authorities to reassess their economic assumptions, highlighting growing vulnerabilities in export-dependent industries. The revised GDP forecast underscores the sensitivity of Denmark’s economy to shifts in international trade policies and sector-specific headwinds.
— news from Bloomberg.com
— News Original —
Denmark Slashes Economic Growth Forecast as Novo Nordisk Slumps
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world n nConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world n nDenmark is cutting its forecast for 2025 economic growth by more than half amid weaker prospects for pharmaceutical giant Novo Nordisk A/S , according to government documents seen by Bloomberg News. n nGross domestic product is expected to expand 1.4% this year, down from the government’s May estimate of 3%, the documents showed. The government cited US tariff increases and a weakened outlook for the pharmaceutical industry as drivers for the revision.